Atrium Innovations Inc. (ATB.TO)
15.11CAD
18 Dec 2009
$-0.23 (-1.50%)
$15.34
$15.45
$15.45
$15.01
47,528
62,319
$16.89
$11.27
ATB.TO
About
Overall
| Beta: | 0.68 |
| Market Cap (Mil.): | $502.89 |
| Shares Outstanding (Mil.): | 32.66 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| ATB.TO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 10.41 | 6.59 | 4.64 |
| EPS (TTM): | 13.16 | -- | -- |
| ROI: | 8.82 | 6.05 | 2.79 |
| ROE: | 15.47 | 9.06 | 3.51 |
CANADA STOCKS-TSX may rise on oil, eye on banks
TORONTO, Feb 26 (Reuters) - Toronto's main stock index is poised to climb at the open on Thursday as oil prices rose, but quarterly bank results and falling gold prices may offset.
CANADA RESEARCH SUMMARY: Jan 6 1534 GMT
Following is a summary of research actions on Canadian companies reported by Reuters on Tuesday. Stock entries are in alphabetical order. For a summary of research on S&P 500 companies, double click on [RCH/US] For a summary of research on non-S&P 500 companies, double click on [RCH/US2] --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION Angle Energy Haywood Cuts price target by C$1
CANADA STOCKS-Toronto index headed for lower open
TORONTO, Jan 5 (Reuters) - Toronto's main stock index is seen opening slightly lower on Monday, reversing some of the sharp gains recorded last week as investors return from holidays to confront the slumping global economy.
CANADA RESEARCH SUMMARY: Oct 9 1932 GMT
Following is a summary of research actions on Canadian companies reported by Reuters on Thursday. Stock entries are in alphabetical order. For a summary of research on S&P 500 companies, double click on [RCH/US] For a summary of research on non-S&P 500 companies, double click on [RCH/US2] --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION Action Energy BMO Cuts to underperform -
UPDATE 1-Atrium results boosted by unit sale gain
TORONTO, Aug 7 (Reuters) - Atrium Innovations's quarterly profit jumped more than sixfold, helped by a gain on the sale of its Active Ingredients and Specialty Chemicals division, the Canadian pharmaceuticals company said on Thursday.
UPDATE 1-Atrium Innovations to sell active ingredients unit
TORONTO, April 4 (Reuters) - Canadian pharmaceuticals company Atrium Innovations said on Friday it plans to sell its Active Ingredients and Specialty Chemicals division to Paris-based AXA Private Equity for $155 million as it shifts its focus to the health and nutrition segments of the market.
Atrium Innovations to sell active incredients unit
TORONTO, April 4 (Reuters) - Atrium Innovations said on Friday that it planned to sell its Active Ingredients and Specialty Chemicals division to a global private equity firm for $155 million as it shifts its focus to the health and nutrition segments.
UPDATE 4-Atrium announces European deal, stock jumps
TORONTO, July 12 (Reuters) - Atrium Innovations said on Thursday it plans to buy Mucos Emulsions GmbH in an all-cash deal worth $175 million, giving it an entry into the European health and nutrition market.
Toronto stocks jump to record high on Alcan bid
TORONTO, July 12 (Reuters) - Toronto's main stock index rose to a record high on Thursday morning, boosted by Rio Tinto's $38.1 billion takeover offer for Alcan , while energy shares rose on higher crude prices despite a production warning from oil company Nexen .
Alcan deal seen pushing Toronto stocks to record
TORONTO, July 12 (Reuters) - Toronto stocks may test a new high on Thursday as Rio Tinto's US$38.1 billion offer for Alcan boosts materials stocks, but weak results and a warning of lower production at Nexen Inc. could weigh on energy shares.
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
